December 16, 2015
Mitsubishi Tanabe Pharma has inked a deal with Akebia Therapeutics to obtain exclusive rights to the US firm’s oral anemia therapy vadadustat in Japan and certain other Asian countries, the two companies said on December 15. Besides Japan, the Japanese...read more